SIRT1 and gastric cancer: miR-543 can promote gastric cancer cell proliferation by targeting SIRT1[35] and miR-204 can down-regulate SIRT1 and revert SIRT1-induced epithelial-mesenchymal transition, anoikis resistance, and invasion in gastric cancer[36].